First Subjects Enrolled in Epigenomics Sponsored PRESEPT Colorectal Cancer Screening Study
30 juin 2008 03h07 HE
|
Epigenomics AG
SEATTLE and BERLIN, June 30, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection...
Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection
18 juin 2008 03h12 HE
|
Epigenomics AG
BERLIN and SEATTLE, June 18, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection...
Epigenomics Successfully Completes Clinical Study in Lung Cancer Diagnosis
09 juin 2008 02h38 HE
|
Epigenomics AG
BERLIN and SEATTLE, June 9, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer based on...
Epigenomics AG Reports First Quarter 2008 Financial Results
06 mai 2008 02h55 HE
|
Epigenomics AG
Key Figures
-- Revenue: EUR 0.9 million in Q1 2008, up by 12% (Q1 2007: EUR 0.8
million)
-- EBIT: EUR -3.0 million in Q1 2008, improved by 13% (Q1 2007: EUR
-3.4 million)
-- Net loss:...
Epigenomics AG Successfully Validates Optimized Blood-Based Colorectal Cancer Assay in Two Independent Clinical Studies
21 avr. 2008 02h17 HE
|
Epigenomics AG
BERLIN and SEATTLE, April 21, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer based on...
Epigenomics AG Presents Data on Novel Prostate Cancer Biomarkers at AACR
14 avr. 2008 02h41 HE
|
Epigenomics AG
BERLIN and SEATTLE, April 14, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing on the development and commercialization of in-vitro...
Epigenomics and TIB MOLBIOL Launch First in a Series of Products At Analytica 2008
01 avr. 2008 03h15 HE
|
Epigenomics AG
BERLIN and SEATTLE, April 1, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECS) (Prime Standard), a molecular diagnostics company developing products based on DNA methylation analysis, together...
Epigenomics AG Reports Financial Results for a Successful Fiscal Year 2007
31 mars 2008 02h18 HE
|
Epigenomics AG
Successful execution on corporate strategy - Financial and strategic
framework set for the future
Financials in line with latest expectations:
-- Full year revenue EUR 2.6 million
--...
Announcement acc. to Sections 37v-x WpHG: Epigenomics AG: Announcement According to Sections 37v, 37w, 37x, 37y WpHG With the Aim of European-Wide Distribution
13 mars 2008 10h54 HE
|
Epigenomics AG
BERLIN, March 13, 2008 (PRIME NEWSWIRE) -- Advance announcement on the disclosure of financial statements by Epigenomics AG.
Epigenomics AG hereby announces that in the fiscal year 2008 the...
Epigenomics AG to Host Press Conference and Analyst Meeting for 2007 Annual Results
13 mars 2008 07h23 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, March 13, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company, will hold its annual press conference and analyst meeting on...